Isotretinoin, a form of vitamin A, has been prescribed to treat acne for decades. It reduces oil production in the skin, which helps prevent acne from forming.
Dec 28, 2018
0
217
(HealthDay)—In a finding that could lead to new treatments for acne, scientists say they've discovered a previously unrecognized way in which bacteria trigger inflammation in the skin.
Oct 29, 2016
0
129
Got grapes? UCLA researchers have demonstrated how resveratrol, an antioxidant derived from grapes and found in wine, works to inhibit growth of the bacteria that causes acne.
Sep 30, 2014
0
0
A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.
May 24, 2012
0
0
A week ago, you started a new prescription medication for acne. Today, you feel dizzy and short of breath and have difficulty concentrating. Your symptoms are not listed in the package insert as possible side effects of the ...
Mar 14, 2012
0
0
(Medical Xpress) -- With 85 percent of teenagers and some 40 million Americans suffering with acne, researchers from the University of California and the vaccine company Sanofi-Pasteur announced they are coming together to ...
For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) ...
Jul 17, 2024
0
0
In a study in the Journal of Cosmetic Dermatology that included 60 individuals with mild to moderate acne, following the Mediterranean diet and taking omega-3 fatty acid supplements led to significant reductions in inflammatory ...
Jul 10, 2024
0
0
Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.
Jun 8, 2024
0
0
In a small pilot study, some young women looking to lose weight on a low-calorie keto diet got an unexpected benefit: Their acne began to clear up.
May 15, 2024
0
0
